What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
The scientist’s investigation covers issues in Internal medicine, Immunology, Antiphospholipid syndrome, Lupus erythematosus and Surgery.
Many of his studies involve connections with topics such as Gastroenterology and Internal medicine.
His Immunology research incorporates elements of Disease, Incidence and Family medicine.
His Antiphospholipid syndrome study focuses on Catastrophic antiphospholipid syndrome in particular.
He has researched Lupus erythematosus in several fields, including Randomized controlled trial, Nephropathy, Systemic lupus erythematosus, Belimumab and Anti-SSA/Ro autoantibodies.
The Surgery study combines topics in areas such as Cause of death and Obstetrics.
His most cited work include:
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). (4564 citations)
- Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients (1443 citations)
- Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients (962 citations)
What are the main themes of his work throughout his whole career to date?
Ricard Cervera spends much of his time researching Internal medicine, Immunology, Antiphospholipid syndrome, Antibody and Thrombosis.
His Internal medicine study combines topics in areas such as Gastroenterology and Surgery.
Immunology connects with themes related to Disease in his study.
His study looks at the intersection of Antiphospholipid syndrome and topics like Lupus anticoagulant with Anticardiolipin antibodies.
In Catastrophic antiphospholipid syndrome, he works on issues like Rituximab, which are connected to Refractory.
His Lupus erythematosus study combines topics from a wide range of disciplines, such as Systemic lupus erythematosus and Anti-SSA/Ro autoantibodies.
He most often published in these fields:
- Internal medicine (40.29%)
- Immunology (36.48%)
- Antiphospholipid syndrome (35.39%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (40.29%)
- Antiphospholipid syndrome (35.39%)
- Immunology (36.48%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Antiphospholipid syndrome, Immunology, Intensive care medicine and Antibody.
His studies link Gastroenterology with Internal medicine.
Ricard Cervera is studying Catastrophic antiphospholipid syndrome, which is a component of Antiphospholipid syndrome.
His Immunology study deals with Disease intersecting with Genotype.
His study in the field of Anticardiolipin antibodies is also linked to topics like In patient, International congress and Task force.
As a part of the same scientific family, Ricard Cervera mostly works in the field of Lupus anticoagulant, focusing on Hydroxychloroquine and, on occasion, Systemic lupus erythematosus.
Between 2015 and 2021, his most popular works were:
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. (372 citations)
- EULAR recommendations for the management of antiphospholipid syndrome in adults (215 citations)
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (197 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Internal medicine, Antiphospholipid syndrome, Immunology, Disease and Rheumatology are his primary areas of study.
His Internal medicine study frequently draws parallels with other fields, such as Lupus erythematosus.
His Antiphospholipid syndrome study results in a more complete grasp of Thrombosis.
His study on Rare disease is often connected to Clinical Practice as part of broader study in Disease.
His Rheumatology study incorporates themes from Disease management, Incidence and Intensive care medicine.
His studies in Gastroenterology integrate themes in fields like Lupus anticoagulant and Plasma samples.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
